查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1957288

皮膚病影像市場－全球產業規模、佔有率、趨勢、機會、預測：影像方法、應用、終端用戶、區域及競爭格局（2021-2031年）

Dermatology Imaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Imaging Modality, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球皮膚影像市場預計將從 2025 年的 77.5 億美元大幅成長至 2031 年的 149.1 億美元，複合年成長率達到 11.51%。

該領域涵蓋皮膚鏡檢查和光學同調斷層掃描(OCT) 等非侵入性技術，這些技術對於診斷過程中皮膚結構的可視化至關重要。市場成長的主要促進因素包括全球皮膚癌發病率的上升以及早期檢測能力的重要性，此外，人口老化和人們對非侵入性診斷方法的日益青睞也推動了這一成長。美國癌症協會估計，到 2025 年，美國將新增 104,960 例侵襲性黑色素瘤病例，進一步凸顯了開發可靠診斷解決方案的迫切性。

市場概覽
預測期 2027-2031
市場規模：2025年 77.5億美元
市場規模：2031年 149.1億美元
複合年成長率：2026-2031年 11.51%
成長最快的細分市場 數位照片
最大的市場 北美洲

阻礙市場擴張的主要障礙之一是先進診斷影像設備的高成本。部署高解析度系統所需的大量資本投入限制了其在預算有限的醫療機構中的普及。因此，這種經濟負擔給發展中地區的小規模診所和醫療機構帶來了阻礙，影響了這些技術的推廣，並阻礙了市場的整體成長。

市場促進因素

人工智慧 (AI) 和機器學習的融合正在從根本上改變全球皮膚影像市場，提高診斷準確率並擴大其可及性。這些技術使基層醫療人員能夠以以往只有專科醫生才能達到的準確度評估可疑病變，從而滿足及時干預的迫切需求。該領域的一個重要里程碑是，首款用於皮膚癌檢測的 AI醫療設備獲得了 FDA核准。根據 DermaSensor 公司於 2024 年 1 月發布的 FDA 批准公告，該設備在 224 例皮膚癌篩檢中達到了 96% 的靈敏度，顯著高於標準的基層醫療檢測率。這項技術進步可在臨床實踐中提供即時、客觀的結果，簡化診斷流程並減少不必要的轉診。

同時，遠距皮膚病學和遠距離診斷的普及正在突破地域限制，最佳化醫療流程，從而擴大市場。這一轉變對於應對日益嚴重的全球皮膚病負擔至關重要。 2024年，黑色素瘤防治基金會（Aim at Melanoma Foundation）預測，2040年，全球每年新增惡性黑色素瘤病例將達51萬例。為了應對如此龐大的病例數量，醫療系統正在利用遠端影像技術，有效地優先處理高風險患者。例如，巴茨健康NHS信託泰銖）於2024年4月發布的《遠距皮膚病學試點結果》報告顯示，在引入新的數位化管道後，疑似皮膚癌患者在就診兩週內確診的比例提高到94%。這比2022年的平均水準62%有了顯著提高，充分體現了遠距離診斷工具在皮膚病學服務現代化進程中發揮的關鍵作用。

市場挑戰

先進皮膚影像系統所需的巨額資本投入是限制市場擴張的主要阻礙因素。採用高解析度光學和數位分析技術的設備初始成本極高，難以推廣應用，尤其是在開發中國家的小規模私人診所和醫療機構。這種資金需求構成了進入門檻，阻礙了這些診斷工具在各種醫療機構中的廣泛應用。當醫療專業人員必須承擔高昂的購買成本而無法即時獲得收益保證時，這些設備的普及應用就會被顯著延緩，直接影響全球市場的成長軌跡。

營運成本和報銷率的降低使得投資昂貴的影像設備變得更加困難。據美國醫學會 (AMA) 稱，2024 年聯邦醫療保險 (Medicare) 醫生報銷額度削減 1.25% 將進一步給醫療機構帶來財務壓力。這種緊縮政策將限制用於升級診斷基礎設施的預算，導致許多皮膚科醫生推遲或放棄購買先進的影像設備。這種經濟環境正在縮小製造商的潛在基本客群，並阻礙市場充分發揮商業性潛力。

市場趨勢

3D全身影像技術的廣泛應用正在革新黑色素瘤監測方式，使其從單一病灶評估轉向全身影像。這些系統利用高解析度相機陣列，產生患者的數位雙胞胎，使臨床醫生能夠以前所未有的精度監測痣的進展並檢測細微變化。這種自動化流程規範了高風險患者的記錄，並有助於進行高效的時間序列監測。 Canfield Scientific公司2024年7月發布的公告「ACEMID獲得津貼，在Mildura Base公立醫院部署VECTRA WB360系統，擴大網路覆蓋範圍」充分體現了這項技術的部署規模。該公告指出，澳洲黑色素瘤成像卓越中心（ACEMID）已將其用於皮膚癌篩檢的VECTRA WB360系統網路擴展至16個地點。

同時，影像技術正滲透到美容皮膚科領域，為客觀的皮膚分析和治療模擬提供支援。診斷工具的改進使其能夠可視化皮膚類型和日曬損傷等指標，從而幫助醫療專業人員量化老化徵兆並檢驗美容療程的效果。影像診斷設備能夠提供可視化證據，使其在患者諮詢中不可或缺，有效彌合了患者期望與臨床實際情況之間的差距。這一趨勢在行業評估中也得到了印證。根據 QuantifiCare 公司 2024 年 3 月發布的公告“LifeViz Mini Pro 榮獲 2024 年度最佳美容設備獎”，該公司的 3D 成像診斷產品線第五次榮獲該獎項，再次印證了該領域對專業視覺化系統的高度依賴。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球皮膚影像市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 診斷影像方法（數位攝影影像、皮膚鏡檢查等）
    • 適用範圍（色素性病變、乾癬、皮膚癌、整形/重組手術等）
    • 依最終使用者（醫院、專科診所、皮膚修復中心）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美皮膚影像市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲皮膚影像市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區皮膚影像市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲皮膚影像市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲皮膚影像市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球皮膚病影像市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Navitar Inc.
  • E-Control Systems Inc.
  • Caliberid Imaging & Diagnostics Inc.
  • Emage Medical LLC
  • Courage+Khazaka electronic GmbH
  • Atys Medical SAS
  • Longport Inc.
  • Cortex Technology ApS
  • Canfield Scientific Inc.
  • Taberna Pro Medicum GmbH

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23450

The Global Dermatology Imaging Market is projected to experience substantial growth, rising from a valuation of USD 7.75 Billion in 2025 to USD 14.91 Billion by 2031, achieving a CAGR of 11.51%. This sector encompasses noninvasive technologies, such as dermatoscopy and optical coherence tomography, which are essential for visualizing skin structures during diagnosis. The market's momentum is primarily fueled by the increasing global incidence of skin cancers and the critical necessity for early detection capabilities, trends that are reinforced by an aging demographic and a growing preference for noninvasive diagnostic methods. Underscoring this urgency, the American Cancer Society estimates that 104,960 new cases of invasive melanoma will be diagnosed in the United States in 2025, highlighting the imperative for robust diagnostic solutions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 7.75 Billion
Market Size 2031USD 14.91 Billion
CAGR 2026-203111.51%
Fastest Growing SegmentDigital Photographic Imaging
Largest MarketNorth America

One major obstacle hindering market expansion is the substantial cost associated with advanced imaging equipment. The significant capital investment required to acquire high-resolution systems limits their availability in healthcare environments with restricted budgets. Consequently, this financial strain on smaller clinics and facilities in developing regions curtails the widespread adoption of these technologies and impedes the overall growth trajectory of the market.

Market Driver

The incorporation of Artificial Intelligence and Machine Learning is fundamentally transforming the Global Dermatology Imaging Market by elevating diagnostic precision and broadening accessibility. These technologies empower primary care providers to assess suspicious lesions with a degree of accuracy formerly exclusive to specialists, thereby addressing the vital need for timely intervention. A major milestone in this field was reached when the FDA cleared the first AI-enabled medical device designed for skin cancer detection. As reported by DermaSensor Inc. in their January 2024 'FDA Clearance Announcement,' the device achieved a sensitivity of 96 percent across 224 tested skin cancers, significantly surpassing standard primary care detection rates. This technological advancement permits immediate, objective results at the point of care, effectively streamlining the diagnostic workflow and reducing the frequency of unnecessary referrals.

Concurrently, the increasing use of teledermatology and remote diagnostics is extending market reach by overcoming geographical limitations and optimizing healthcare processes. This shift is crucial for managing the escalating global burden of skin conditions; the Aim at Melanoma Foundation noted in 2024 that annual new melanoma diagnoses worldwide are expected to rise to 510,000 by 2040. To handle such volumes, healthcare systems are utilizing remote imaging to prioritize high-risk patients efficiently. For instance, Barts Health NHS Trust reported in their April 2024 'Teledermatology Pilot Results' that the implementation of a new digital pathway improved the proportion of suspected skin cancer patients seen within two weeks to 94 percent, a significant increase from the 62 percent average in 2022, demonstrating the essential role of remote diagnostic tools in modernizing dermatology services.

Market Challenge

The significant capital investment necessary for advanced dermatology imaging systems constitutes a primary restraint on market expansion. Technologies utilizing high-resolution optics and digital analysis entail substantial upfront costs that restrict their accessibility, particularly for smaller private clinics and healthcare facilities in developing nations. This financial requirement creates a barrier to entry, preventing the widespread adoption of these diagnostic tools across various healthcare settings. When practitioners face high acquisition costs without the assurance of immediate financial returns, the uptake of these devices slows considerably, directly affecting the overall growth trajectory of the global market.

Operational expenditures and declining reimbursement rates further exacerbate the difficulty of investing in expensive imaging capital. According to the American Medical Association, the Medicare physician payment schedule was reduced by 1.25 percent in 2024, placing additional financial pressure on medical practices. This fiscal tightening limits the budget available for upgrading diagnostic infrastructure, compelling many dermatologists to postpone or forego the purchase of advanced imaging units. This economic environment restricts the potential customer base for manufacturers and hinders the market's ability to realize its full commercial potential.

Market Trends

The increasing utilization of 3D total body photography is revolutionizing melanoma surveillance by shifting the focus from individual lesion assessment to comprehensive whole-body mapping. These systems employ high-resolution camera arrays to generate a digital twin of the patient, enabling clinicians to monitor the evolution of moles and detect subtle changes with unprecedented accuracy. This automation standardizes documentation for high-risk patients, facilitating efficient longitudinal monitoring. The scale of such adoption is illustrated by Canfield Scientific's July 2024 announcement regarding the 'ACEMID Expands Network with Grant to Install VECTRA WB360 at Mildura Base Public Hospital,' which noted that the Australian Centre of Excellence in Melanoma Imaging & Diagnosis has successfully grown to include a 16th site using the VECTRA WB360 system for skin cancer screening.

Simultaneously, imaging technologies are penetrating the field of aesthetic dermatology to support objective skin analysis and treatment simulation. Diagnostic tools are being adapted to visualize metrics like texture and sun damage, allowing practitioners to quantify signs of aging and validate cosmetic treatments. The ability to provide visual evidence has made imaging units essential for patient consultations, effectively bridging the gap between patient expectations and clinical realities. This trend is highlighted by industry recognition; according to QuantifiCare's March 2024 'LifeViz Mini Pro Awarded Best Aesthetic Device 2024' announcement, their 3D imaging range received the Best Aesthetic Device award for the fifth time, confirming the sector's strong reliance on specialized visualization systems.

Key Market Players

  • Navitar Inc.
  • E-Control Systems Inc.
  • Caliberid Imaging & Diagnostics Inc.
  • Emage Medical LLC
  • Courage + Khazaka electronic GmbH
  • Atys Medical SAS
  • Longport Inc.
  • Cortex Technology ApS
  • Canfield Scientific Inc.
  • Taberna Pro Medicum GmbH

Report Scope

In this report, the Global Dermatology Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dermatology Imaging Market, By Imaging Modality

  • Digital Photographic Imaging
  • Dermoscopy
  • Others

Dermatology Imaging Market, By Application

  • Pigmented Lesions
  • Psoriasis
  • Skin Cancer
  • Plastic and Reconstructive Surgery
  • Others

Dermatology Imaging Market, By End User

  • Hospitals
  • Specialty Clinics
  • Skin Rejuvenation Centers

Dermatology Imaging Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dermatology Imaging Market.

Available Customizations:

Global Dermatology Imaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dermatology Imaging Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Imaging Modality (Digital Photographic Imaging, Dermoscopy, Others)
    • 5.2.2. By Application (Pigmented Lesions, Psoriasis, Skin Cancer, Plastic and Reconstructive Surgery, Others)
    • 5.2.3. By End User (Hospitals, Specialty Clinics, Skin Rejuvenation Centers)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Dermatology Imaging Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Imaging Modality
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Dermatology Imaging Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Imaging Modality
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Dermatology Imaging Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Imaging Modality
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Dermatology Imaging Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Imaging Modality
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Dermatology Imaging Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Imaging Modality
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Dermatology Imaging Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Imaging Modality
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Dermatology Imaging Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Imaging Modality
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Dermatology Imaging Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Imaging Modality
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Dermatology Imaging Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Imaging Modality
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Dermatology Imaging Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Imaging Modality
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia Pacific Dermatology Imaging Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Imaging Modality
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Dermatology Imaging Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Imaging Modality
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Dermatology Imaging Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Imaging Modality
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Dermatology Imaging Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Imaging Modality
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Dermatology Imaging Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Imaging Modality
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Dermatology Imaging Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Imaging Modality
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Middle East & Africa Dermatology Imaging Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Imaging Modality
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Dermatology Imaging Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Imaging Modality
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Dermatology Imaging Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Imaging Modality
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Dermatology Imaging Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Imaging Modality
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. South America Dermatology Imaging Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Imaging Modality
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Dermatology Imaging Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Imaging Modality
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Dermatology Imaging Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Imaging Modality
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Dermatology Imaging Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Imaging Modality
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Dermatology Imaging Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Navitar Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. E-Control Systems Inc.
  • 15.3. Caliberid Imaging & Diagnostics Inc.
  • 15.4. Emage Medical LLC
  • 15.5. Courage + Khazaka electronic GmbH
  • 15.6. Atys Medical SAS
  • 15.7. Longport Inc.
  • 15.8. Cortex Technology ApS
  • 15.9. Canfield Scientific Inc.
  • 15.10. Taberna Pro Medicum GmbH

16. Strategic Recommendations

17. About Us & Disclaimer